Acrivon Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.4k | 695 | 4.92 |
| 2023-09-30 | $6.6k | 695 | 9.56 |
| 2023-06-30 | $9.0k | 695 | 12.96 |
| 2023-03-31 | $8.8k | 695 | 12.69 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors